• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    908 Devices Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

    4/30/24 8:01:21 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials
    Get the next $MASS alert in real time by email
    false 0001555279 0001555279 2024-04-29 2024-04-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d)
    OF THE SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): April 29, 2024

     

     

    908 Devices Inc.

    (Exact name of registrant as specified in its charter)

     

     

    Delaware   001-39815   45-4524096

    (State or Other Jurisdiction
    of Incorporation) 

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.) 

     

    645 Summer Street

    Boston, MA  02210

    (Address of principal executive offices, including zip code)

     

    (857) 254-1500
    (Registrant’s telephone number, including area code)

     

    Not Applicable
    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act: 

     

    Title of each class Trading Symbol(s) Name of each exchange on which registered
    Common Stock, par value $0.001 per share MASS The Nasdaq Global Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 ( §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company  x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

     

     

     

     

     

     

    Item 1.01.  Entry into a Material Definitive Agreement.

     

    Equity Purchase Agreement

     

    On April 29, 2024, 908 Devices Inc. (the “Company”), entered into an Equity Purchase Agreement (the “Purchase Agreement”) with CAM2 Technologies, LLC, a Connecticut limited liability company (d/b/a RedWave Technology) (“RedWave”), CAM3 HoldCo, LLC, a Connecticut limited liability company (“Seller Entity”), each of the holders of outstanding equity interests of Seller Entity (the “Beneficial Sellers”, together with the Seller Entity, the “Sellers”), and Jon Frattaroli, in his capacity as a guarantor for a Beneficial Seller that is an entity pursuant to Section 10.14 of the Purchase Agreement (the “Indirect Beneficial Seller”). RedWave is a provider of portable FTIR spectroscopic analyzers for rapid chemical identification of bulk materials.

     

    Pursuant to the Purchase Agreement, Company purchased, all of Seller Entity’s right, title and interest in and to all of the issued and outstanding equity interests of RedWave (the “Transaction”), in exchange for an initial payment of $45.0 million in cash (the “Cash Consideration”), and 1,497,171 unregistered shares of common stock, par value $0.001, of the Company (the “Company Common Stock”), which reflects closing adjustments relating to working capital, cash and debt adjustments as set forth in the Purchase Agreement (the “Closing Shares” and together with the Cash Consideration, the “Closing Consideration”). The Cash Consideration is subject to additional working capital, cash, debt, and transaction expense adjustments as set forth in the Purchase Agreement. The Purchase Agreement also provides that approximately $4.5 million of the Cash Consideration will be placed into an indemnification escrow account for a 12-month period following the Closing Date (as defined below) to settle certain claims for indemnification for breaches or inaccuracies in RedWave’s representations and warranties, covenants, and agreements. The Transaction closed on April 29, 2024 (the “Closing Date”), at which time RedWave became a wholly-owned subsidiary of the Company.

     

    Pursuant to the Purchase Agreement, the Company may also be obligated to issue up to an additional 4,000,000 unregistered shares of Company Common Stock (the “Earnout Shares” and, together with the Closing Shares, the “Shares”) as contingent consideration based on the amount of revenue the Company generates from the sale of certain RedWave products and services (“Earnout Revenue”) during the 2-year period from May 1, 2024 through April 30, 2026 (the “Earnout Period”) as provided in the Purchase Agreement (the “Earnout Milestone”). If the Earnout Revenue achieved during the Earnout Period is at least $37 million, the Company will be obligated to issue at least 1,000,000 Earnout Shares, which number of Earnout Shares will be increased based on the amount of Earnout Revenue achieved during the Earnout Period as provided in the Purchase Agreement, up to a maximum of 4,000,000 Earnout Shares for Earnout Revenue equal to or greater than $45 million. The Earnout Revenue also may include certain qualified bookings credit for certain RedWave products in the event that Earnout Revenue is otherwise above $37 million. No Earnout Shares will be issued if the Earnout Revenue achieved during the Earnout Period is less than $37 million.

     

    The Transaction and the Purchase Agreement were unanimously approved by the board of directors of the Company, the members of Seller Entity and the Seller Entity in its capacity as the sole member of RedWave. The Purchase Agreement contains customary representations, warranties, and covenants by each of the parties. Certain of the Beneficial Sellers are also subject to customary non-competition, non-solicitation and non-disparagement covenants for a period of up to 5 years following the Closing Date.

     

    In connection with the Transaction, each of the Beneficial Sellers and certain Seller Entity bonus recipients receiving Closing Shares entered into a lock-up agreement (the “Lock-Up Agreement”) with the Company, pursuant to which each Beneficial Seller and each such Seller Entity bonus recipient agrees not to sell or transfer the Closing Shares for a 180-day lockup period following the Closing Date, subject to customary exceptions.

     

    There are no material relationships among the Company and RedWave or any of their respective affiliates or any of the other parties to the Purchase Agreement or the related ancillary agreements, other than in respect of such agreements.

     

    The foregoing descriptions of the Purchase Agreement and Lock-Up Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the Purchase Agreement and Lock-Up Agreement, respectively, which are filed with this Current Report on Form 8-K as Exhibit 2.1 and Exhibit 10.1, respectively, and each of which incorporated by reference herein in their entirety.

     

     

    The Purchase Agreement has been included to provide investors and stockholders with information regarding its terms. It is not intended to provide any other factual information about the Company or RedWave. The representations, warranties and covenants contained in the Purchase Agreement were made only for purposes of that agreement and as of specific dates, were solely for the benefit of the parties to the Purchase Agreement, may be subject to limitations agreed upon by the contracting parties (including being qualified by confidential disclosures made for the purposes of allocating contractual risk among the various parties to the Purchase Agreement instead of establishing these matters as facts), and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors. Investors are not third-party beneficiaries under the Purchase Agreement and should not rely on the representations, warranties or covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the Company or RedWave or any of their respective subsidiaries or affiliates. Moreover, information concerning the subject matter of the representations and warranties may change after the date of the Purchase Agreement, which subsequent information may or may not be fully reflected in our public disclosures.

     

    Item 2.01. Completion of Acquisition or Disposition of Assets.

     

    The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.01.

     

    Item 3.02. Unregistered Sale of Equity Securities.

     

    The information in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02. Furthermore, subject to the achievement of the Earnout Milestone, the Company may issue up to 4,000,000 unregistered shares of its Common Stock as Earnout Shares, based on the level of achievement of the Earnout Milestone pursuant to the terms of the Purchase Agreement and as set forth in Item 1.01.

     

    The Closing Shares that will be issued upon the closing of the Transaction and the Earnout Shares, if any, to be issued after the closing of the transaction, will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act.

     

    Item 7.01. Regulation FD Disclosure.

     

    On April 30, 2024, the Company issued a press release announcing that it had entered into the Purchase Agreement. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

     

    The information in this Item 7.01 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.

     

    Item 9.01. Financial Statements and Exhibits.

     

    (a) Financial Statements of Business Acquired.

     

    The financial statements of RedWave required by this item will be filed by amendment to this Current Report on Form 8-K no later than 71 calendar days after the date this Current Report on Form 8-K is required to be filed.

     

     

    (b) Pro Forma Financial Information,

     

    The pro forma financial information required by this item will be filed by amendment to this Current Report on Form 8-K no later than 71 calendar days after the date this Current Report on Form 8-K is required to be filed.

     

    (d) Exhibits

     

    Exhibit
     No.
      Description
    2.1   Equity Purchase Agreement dated as of April 29, 2024, by and among 908 Devices Inc., CAM2 Technologies, LLC (d/b/a RedWave Technologies), CAM3 HoldCo, LLC, each of the Beneficial Sellers named therein and the Indirect Beneficial Seller named therein.
       
    10.1   Form of Lock-Up Agreement
       
    99.1   Press Release issued by 908 Devices Inc. on April 30, 2024.
         
    104   Cover Page Interactive Data File (embedded within the inline XBRL document)

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      908 DEVICES INC.
         
    Date: April 30, 2024 By: /s/ Michael S. Turner
        Name: Michael S. Turner
        Title:   Chief Legal and Administrative Officer  

     

     

    Get the next $MASS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MASS

    DatePrice TargetRatingAnalyst
    8/5/2025$12.00Market Perform → Outperform
    Leerink Partners
    11/13/2024$12.00 → $4.00Outperform → Market Perform
    Leerink Partners
    2/7/2023$14.00Overweight
    Stephens
    3/8/2022$40.00 → $30.00Outperform
    SVB Leerink
    10/15/2021Outperform
    Cowen
    More analyst ratings

    $MASS
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by 908 Devices Inc.

    SCHEDULE 13G - 908 Devices Inc. (0001555279) (Subject)

    2/9/26 6:14:22 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    908 Devices Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - 908 Devices Inc. (0001555279) (Filer)

    1/20/26 7:15:12 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by 908 Devices Inc.

    SCHEDULE 13G/A - 908 Devices Inc. (0001555279) (Subject)

    12/5/25 4:32:08 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    $MASS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    908 Devices Enhances MX908 Usability and Adds New Drug Targets

    New mission mode provides simpler and more intuitive sampling of hazardous vapors 908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces new capabilities for its handheld MX908 mass spectrometry device for trace chemical identification. These enhancements include an updated mission mode for hazardous vapor sampling and the addition of five priority drug targets, providing first responders with intelligence at the point of need for an informed, confident response. The MX908 mission modes, which include Drug Hunter, Explosives Hunter, and CW (chemical warfare) Hunter, have matured into the most powerful and complete capabilities in the

    2/5/26 7:00:00 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025

    Preliminary full year 2025 revenue of approximately $56 million, representing ~17% growth year-over-year Achieved positive Adjusted EBITDA goal in the fourth quarter 908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced preliminary unaudited financial results for the quarter and full year ended December 31, 2025. Preliminary unaudited revenue for the fourth quarter of 2025 is approximately $17.2 million, compared to $14.3 million in the fourth quarter of 2024, reflecting reported growth of approximately 20%. Fourth quarter strength was driven by c

    1/20/26 7:00:00 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook

    Year-to-date revenue increased 16% while Adjusted EBITDA loss improves 53% quarter over quarter 908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended September 30, 2025. "We are pleased with our year-to-date progress as we continue to build a more predictable and profitable business and bring our 908 Devices 2.0 vision to life," said Kevin J. Knopp, CEO and Co-founder. "Revenue for the first nine months increased 16%, with strong FTIR demand and with 47% of revenues coming from our U.S. state and local channel. T

    11/10/25 7:00:00 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    $MASS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Griffith Joseph H. Iv converted options into 70,141 shares and sold $143,222 worth of shares (23,175 units at $6.18), increasing direct ownership by 51% to 139,896 units (SEC Form 4)

    4 - 908 Devices Inc. (0001555279) (Issuer)

    2/3/26 8:45:22 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    President and CEO Knopp Kevin J. converted options into 107,999 shares and sold $214,842 worth of shares (34,764 units at $6.18), increasing direct ownership by 10% to 795,968 units (SEC Form 4)

    4 - 908 Devices Inc. (0001555279) (Issuer)

    2/3/26 8:45:24 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    Director Spoto Mark gifted 928 shares, received a gift of 928 shares and transferred by will 928 shares), increasing direct ownership by 1% to 75,263 units (SEC Form 4)

    4 - 908 Devices Inc. (0001555279) (Issuer)

    2/3/26 8:45:21 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    $MASS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $MASS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    President and CEO Knopp Kevin J. bought $66,596 worth of shares (15,000 units at $4.44), increasing direct ownership by 2% to 722,733 units (SEC Form 4)

    4 - 908 Devices Inc. (0001555279) (Issuer)

    5/19/25 4:37:42 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    Director Spoto Mark bought $42,850 worth of shares (10,000 units at $4.29), increasing direct ownership by 19% to 62,971 units (SEC Form 4)

    4 - 908 Devices Inc. (0001555279) (Issuer)

    5/15/25 4:52:08 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    President and CEO Knopp Kevin J. bought $64,788 worth of shares (15,000 units at $4.32), increasing direct ownership by 2% to 707,733 units (SEC Form 4)

    4 - 908 Devices Inc. (0001555279) (Issuer)

    5/14/25 4:28:02 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    908 Devices upgraded by Leerink Partners with a new price target

    Leerink Partners upgraded 908 Devices from Market Perform to Outperform and set a new price target of $12.00

    8/5/25 1:46:38 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    908 Devices downgraded by Leerink Partners with a new price target

    Leerink Partners downgraded 908 Devices from Outperform to Market Perform and set a new price target of $4.00 from $12.00 previously

    11/13/24 8:05:47 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    Stephens initiated coverage on 908 Devices with a new price target

    Stephens initiated coverage of 908 Devices with a rating of Overweight and set a new price target of $14.00

    2/7/23 6:37:28 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    $MASS
    Financials

    Live finance-specific insights

    View All

    908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook

    Year-to-date revenue increased 16% while Adjusted EBITDA loss improves 53% quarter over quarter 908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended September 30, 2025. "We are pleased with our year-to-date progress as we continue to build a more predictable and profitable business and bring our 908 Devices 2.0 vision to life," said Kevin J. Knopp, CEO and Co-founder. "Revenue for the first nine months increased 16%, with strong FTIR demand and with 47% of revenues coming from our U.S. state and local channel. T

    11/10/25 7:00:00 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    908 Devices to Report Third Quarter 2025 Financial Results on November 10, 2025

    908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced it will report financial results for the third quarter 2025 before market open on Monday, November 10, 2025. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Live audio of the webcast will be available on the "Investors" section of the company website at: www.908devices.com. The webcast will be archived and available for replay within 24 hours after the event. About 908 Devices 908 Devices is revolutionizing chemical ana

    10/22/25 7:00:00 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook

    Revenue from continuing operations grew 14% compared to prior year 908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended June 30, 2025. "We executed with urgency and discipline in the second quarter, driving strong top-line growth while advancing key structural initiatives to strengthen our financial profile," said Kevin J. Knopp, CEO and Co-founder. "We delivered record XplorIR placements, successfully launched VipIR, and made meaningful progress on our path to profitability. These achievements reinforce our c

    8/5/25 7:00:00 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    $MASS
    Leadership Updates

    Live Leadership Updates

    View All

    908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors

    908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Dr. Brandi Vann to serve on its Board of Directors. During more than 15 years at the U.S. Department of Defense (DoD), Dr. Vann held several leadership positions overseeing nuclear, chemical, and biological defense programs. The company also announces that Jeff George, a veteran biopharma leader, has stepped down from its Board of Directors due to the company's strategic refocus on public health, safety and defense tech. These changes are effective immediately. Previously, Dr. Vann was Performing the Duties of the Assistant Secretary of Defense for Nuclear, Ch

    8/4/25 7:00:00 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    908 Devices Appoints Christopher D. Brown to its Board of Directors

    908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D. Brown, PhD, Vice President, Analytics R&D at Repligen Corporation (NASDAQ:RGEN), and a 908 Devices Co-founder, to serve on its Board of Directors, effective immediately. Dr. Brown co-founded 908 Devices and served as the company's Chief Technology Officer & Vice President of Research & Development from February 2012 to March 2023, and as its Chief Product Officer from March 2023 until March 2025 when Repligen purchased the company's bioprocessing portfolio. Prior to 908 Devices, Dr. Brown was a platform architect at Apple Inc. (NASDAQ:AAPL) lead

    6/16/25 8:00:00 AM ET
    $AAPL
    $MASS
    $RGEN
    Computer Manufacturing
    Technology
    Industrial Machinery/Components
    Industrials

    908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors

    908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, has appointed Michele M. Leonhart, the former Administrator of the United States Drug Enforcement Administration (DEA), to serve on its Board of Directors effective immediately. Ms. Leonhart brings a deep understanding of our customers in law enforcement and adjacent markets. Her 34-year career in the DEA encompassed various positions with increasing levels of responsibility, including Special Agent in Charge of the Los Angeles Field Division from 1998 to 2003, Deputy Administrator (nominated by President Bush) from 2003 to 2007, Acting Administrator from 2007 to 2010, and Admini

    6/25/24 7:00:00 AM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    $MASS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by 908 Devices Inc.

    SC 13G/A - 908 Devices Inc. (0001555279) (Subject)

    11/14/24 5:11:18 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by 908 Devices Inc.

    SC 13G/A - 908 Devices Inc. (0001555279) (Subject)

    11/14/24 4:25:10 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by 908 Devices Inc.

    SC 13G/A - 908 Devices Inc. (0001555279) (Subject)

    7/8/24 4:32:41 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials